Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Evolut™ EXPAND TAVR II Pivotal Trial

NCT05149755

Conditions
Constriction, Pathologic, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
  • Abrazo Arizone Heart Hospital Phoenix, Arizona, United States
  • HonorHealth Scottsdale Shea Medical Center Scottsdale, Arizona, United States
  • Los Robles Hospital & Medical Center Thousand Oaks, California, United States
View all 94 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation

NCT04002297

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center (Bidmc) Boston, Massachusetts, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
View all 176 locations
View Trial Details
Active, Not Recruiting

An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma

NCT02213926

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Tampa, Florida, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Niles, Illinois, United States
  • Research Site Peoria, Illinois, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL)

NCT04661007

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Aichi Cancer Center Hospital Aichi, Japan
  • Chiba Cancer Center Chiba, Japan
  • National Cancer Center Hospital East Chiba, Japan
  • University of Fukui Hospital Fukui, Japan
View all 23 locations
View Trial Details
Active, Not Recruiting

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

NCT02797470

Conditions
Blood-Borne Infections, Burkitt Lymphoma, Communicable Diseases, +41 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions